/oss/taxonomy/term/5146/all en /oss/article/covid-19-health/johnson-johnson-vaccine-welcome-addition-toolbox <p>There are several take-away’s from the Johnson & Johnson trial but most worthy is the 85% efficacy in preventing severe illness and 100% efficacy in preventing deaths in the 28 day period following vaccination. The efficacy in preventing any symptoms was 66%, significantly less than the 90-95% for the Pfizer and Moderna vaccines, and this will likely be portrayed as disappointing. It should not be.</p> Fri, 29 Jan 2021 20:27:19 +0000 Joe Schwarcz PhD 8583 at /oss